- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes and Depression in Japan
Total 1650 results
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Japan
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Japan, Canada, United Kingdom, Denmark, United States
-
Keio UniversityCompleted
-
Jonathan SinclairUniversity of Hertfordshire; Jazan UniversityCompletedDiabetes Mellitus, Type 2Saudi Arabia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Japan, Taiwan, India
-
SanofiCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes | High Blood SugarJapan
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
-
University of JazanSaudi Board of Community MedicineCompletedDepression Literacy | Depression StigmaSaudi Arabia
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines
-
Kyoto UniversityNagoya City UniversityCompleted
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
TakedaCompleted
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Kyoto UniversityNational Center of Neurology and Psychiatry, JapanCompletedUnipolar Major Depressive EpisodeJapan
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)Japan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Listen Trial GroupCompletedHypercholesterolemia With Concomitant Type 2 DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Kumamoto UniversityCompletedCoronary Disease | Arteriosclerosis | Diabetes Mellitus, Type 2Japan
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseGermany, Japan
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Japan, China, Puerto Rico, Romania, Brazil
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
GlaxoSmithKlineCompleted
-
Chiba UniversityCompletedAdolescent | DepressionJapan
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Tokyo Medical UniversityUniversity of Toyama; China Medical University, Taiwan; Chiba University; Japan...CompletedDepression | PregnancyTaiwan, Japan
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Japan, China, India, Mexico, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Spain, China, India, Russian Federation, Turkey, Germany, Japan, United Kingdom, France, United States
-
Eli Lilly and CompanyCompleted
-
Tokyo Medical UniversityUniversity of Toyama; China Medical University, Taiwan; Chiba University; Japan... and other collaboratorsCompletedDepression | PregnancyJapan, Taiwan
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Spain, Taiwan, Japan, Poland, Argentina, Hungary, Puerto Rico, Korea, Republic of, Slovakia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan